Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
BioMarin Pharmaceuticals
Business Segments
Business Segments
Cost of Sales
Cost of Sales
BioMarin Pharmaceuticals
·
Business Segments
·
1 segment
·
Rolls up to
Total Cost of Revenue
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Business Segments
$151.56M
$150.09M
$140.09M
$275.71M
$195M
Total
$151.56M
$150.09M
$140.09M
$275.71M
$195M